Treatment of bifurcation lesions with a thinstrut drug eluting stent with bioresorbablepolymer: three-year clinical outcomes of the CENTURY II trial

Abstract

To demonstrate the safety and efficacy of the Ultimaster, a new sirolimus eluting stent with abluminally , gradient , coated bioresorbable polymer by comparing it with Xience everolimus - eluting stent with circumferencially coated durable polymer with respect to the freedom from Target Lesion Failure at 9 months

Bifurcation substudy compared mid and long - term outcomes in patients with bifurcation lesions treated with bioresorbable polymer DES

Read More

Topics: